ConductScience.org, home
AMY2A: amylase alpha 2A
API referenceFor AI assistants

Gene · 279

Papers797

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 797

Download this page as JSON
TitleJournalYearPMIDFound bySource
Unfolding the Pharmacological Potentialities and Phytochemical Characterization of Pajanelia longifolia (Wild) Leaves: A Multidimensional Study via GC-MS/MS, In Vitro, In Vivo, and In Silico Approaches.
Chem Biodivers202642571622PubTator, text miningPubMed
Design, synthesis, and biological evaluation of a dichloro-substituted schiff base as an α-amylase inhibitor: structural, computational, and molecular dynamics, in-silico approaches.J Biomol Struct Dyn202642543020PubTator, text miningPubMed
Flavonoid C-glycosides in Fabaceae seeds: From structural diversity and functional significance to human health benefits.Food Chem202642442107PubTator, text miningPubMed
Antidiabetic activity of Cassia javanica flowers through in vitro inhibitory evaluation of α-amylase, α-glucosidase and its antiglycation property.Nat Prod Res202642430509PubTator, text miningPubMed
Novel β-defensin-like marine miniprotein magnificamide-2 with a remarkable potency in inhibiting mammalian α-amylases.Int J Biol Macromol202642419540PubTator, text miningPubMed
Design, synthesis, and biological evaluation of p-thymol-derived 1,2,4-triazole sulfonyl hydrazides as potent α-amylase and α-glucosidase inhiabitors: molecular docking and ADME insights.In Silico Pharmacol202642389728PubTator, text miningPubMed
Coumarin-based small molecules for diabetes management: rational design, computational studies, synthesis, and biological evaluation.J Comput Aided Mol Des202642350715PubTator, text miningPubMed
Design, synthesis, biological evaluation, and in silico characterization of chalcone derivatives as antidiabetic hits.Sci Rep202642342702PubTator, text miningPubMed
In vitro alpha amylase and protein denaturation inhibitory activity of newer generation Schiff base Oxazolone derivatives: Synthesis, chemical characterization, molecular docking, MD simulation, DFT, ADMET, and bioactivity.
Biochem Biophys Res Commun202642330886PubTator, text miningPubMed
Convergent evolution through independent rearrangements in the primate amylase locus.Cell Rep202642184164PubTator, text miningPubMed
Identification of putative inhibitors of human pancreatic α-amylase from phytochemicals using molecular docking and computational analysis.Pak J Pharm Sci202642170975PubTator, text miningPubMed
Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants.J Pediatr Gastroenterol Nutr202642037072PubTator, text miningPubMed
Relation of Serum α-Amylase Level With Glycated Hemoglobin and Trace Elements in Patients With Diabetes Mellitus.AACE Endocrinol Diabetes202641938291PubTator, text miningPubMed
Corn bran fiber valorization via feruloylated xylooligosaccharide production: Evaluation of antioxidant and α-amylase and α-glucosidase inhibitory effects.Food Chem202641936784PubTator, text miningPubMed
Multi-target bioactive M(II) pyridine-diamine complexes: synthesis, characterization, in vitro and in silico evaluation.Bioorg Chem202641935403PubTator, text miningPubMed
ADME/drug-likeness and functional properties of Punica granatum seeds supported with molecular docking, GC-MS and LC-MS/MS analysis.Sci Rep202641888218PubTator, text miningPubMed
Unveiling antibacterial and α-amylase inhibitory potentials of Opuntia ficus-indica aqueous extract through LC-ESI-MS/MS-guided in vitro and in silico investigation.Bioorg Chem202641875753PubTator, text miningPubMed
LC-HESI-MS/MS Profiling and Evaluation of Antioxidant, Anti-Inflammatory, Anti-α-Amylase, and Anti-Acetylcholinesterase Activities of Rhus tripartitum L. Leaf Extract: In Vitro and In Silico Studies.Chem Biodivers202641859961PubTator, text miningPubMed
Evaluation of novel topiramate-phenolic acid conjugates as potent pancreatic α-amylase inhibitors: in vitro and in silico insights.J Comput Aided Mol Des202641845153PubTator, text miningPubMed
Decoding the new dimensions of leucodelphinidin as a dual antioxidant and anti-diabetic candidate: A DFT, docking and dynamics evaluation.Biophys Chem202641825389PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/279/papers

API referenceFor AI assistants